Federal Rx Budgets Are Argument Against Patent Extensions - Schumer

The increasing spending by federal health programs on pharmaceuticals should inform Congressional action on pharmaceutical patent issues, Sen. Schumer (D-N.Y.) told the Generic Pharmaceutical Industry Association meeting March 27 in New York City.